Biolife Solutions (BLFS) Total Current Liabilities (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Total Current Liabilities of $18.3 million for Q1 2026, down 34.16% year-over-year from $27.7 million in Q1 2025, and down 20.57% quarter-over-quarter from $23.0 million in Q4 2025.
Biolife Solutions (BLFS) Total Current Liabilities (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Total Current Liabilities for 17 consecutive years, with $18.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 34.16% year-over-year to $18.3 million; the TTM figure through Mar 2026 stood at $18.3 million (down 34.16% YoY), while the FY2025 annual figure was $23.0 million, down 29.8% from the prior year.
- Total Current Liabilities fell to $18.3 million in Q1 2026 per BLFS's latest filing, from $23.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $47.3 million in Q1 2023 and bottomed at $18.3 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $34.7 million across 5 years, with a median of $36.4 million in 2022.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 130.46% — and 2026, when it plunged 34.16%.
- Biolife Solutions' Total Current Liabilities stood at $44.6 million in 2022, then decreased by 5.39% to $42.2 million in 2023, then dropped by 22.39% to $32.7 million in 2024, then decreased by 29.8% to $23.0 million in 2025, then slipped by 20.57% to $18.3 million in 2026.
- Business Quant data shows BLFS's Total Current Liabilities at $18.3 million in Q1 2026, $23.0 million in Q4 2025, and $27.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.05 Bn | 128.83 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.50 Bn | 51.64 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.70 Bn | 34.34 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.66 Bn | 32.19 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.16 Bn | 26.49 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 24.98 Bn | 24.54 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.50 Bn | 11.35 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | 13.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.95 Mn |
| Mar 31, 2026 | 18.25 Mn |
| Dec 31, 2025 | 22.98 Mn |
| Sep 30, 2025 | 27.15 Mn |
| Jun 30, 2025 | 28.31 Mn |
| Mar 31, 2025 | 27.72 Mn |
| Dec 31, 2024 | 32.73 Mn |
| Sep 30, 2024 | 32.17 Mn |
| Jun 30, 2024 | 30.82 Mn |
| Mar 31, 2024 | 38.66 Mn |
| Dec 31, 2023 | 42.18 Mn |
| Sep 30, 2023 | 42.62 Mn |
| Jun 30, 2023 | 39.59 Mn |
| Mar 31, 2023 | 47.32 Mn |
| Dec 31, 2022 | 44.58 Mn |
| Sep 30, 2022 | 40.42 Mn |
| Jun 30, 2022 | 36.37 Mn |
| Mar 31, 2022 | 37.75 Mn |
| Dec 31, 2021 | 42.70 Mn |
| Sep 30, 2021 | 35.79 Mn |